Incidence of and risk factors for ischemic-type biliary lesions following orthotopic liver transplantation

Authors

  • Christoph Heidenhain,

    1.  Department of General, Visceral and Transplantation Surgery, Charité, Campus Virchow, University Medicine Berlin Augustenburger Platz 1, Berlin, Germany
    Search for more papers by this author
  • Johann Pratschke,

    1.  Department of General, Visceral and Transplantation Surgery, Charité, Campus Virchow, University Medicine Berlin Augustenburger Platz 1, Berlin, Germany
    Search for more papers by this author
  • Gero Puhl,

    1.  Department of General, Visceral and Transplantation Surgery, Charité, Campus Virchow, University Medicine Berlin Augustenburger Platz 1, Berlin, Germany
    Search for more papers by this author
  • Ulf Neumann,

    1.  Department of General, Visceral and Transplantation Surgery, Charité, Campus Virchow, University Medicine Berlin Augustenburger Platz 1, Berlin, Germany
    Search for more papers by this author
  • Andreas Pascher,

    1.  Department of General, Visceral and Transplantation Surgery, Charité, Campus Virchow, University Medicine Berlin Augustenburger Platz 1, Berlin, Germany
    Search for more papers by this author
  • Winfried Veltzke-Schlieker,

    1.  Department of Internal Medicine, Division of Gastroenterology and Hepatology Campus Virchow, University Medicine Berlin, Augustenburger Platz 1, Berlin, Germany
    Search for more papers by this author
  • Peter Neuhaus

    1.  Department of General, Visceral and Transplantation Surgery, Charité, Campus Virchow, University Medicine Berlin Augustenburger Platz 1, Berlin, Germany
    Search for more papers by this author

Dr Christoph Heidenhain, Department of General, Visceral and Transplantation Surgery, Charité, Campus Virchow, University Medicine Berlin Augustenburger Platz 1, 13353 Berlin, Germany. Tel.: 0049 30 450 652235; fax: 0049 30 450 552900; e-mail: christoph.heidenhain@charite.de

Summary

Ischemic-type biliary lesions (ITBL) account for a major part of patients’ morbidity and mortality after orthotopic liver transplantation (OLT). The exact origin of this type of biliary complication remains unknown. This study retrospectively evaluated 1843 patients. Patients with primary sclerosing cholangitis were excluded from this study. The diagnosis of ITBL was established only when all other causes of destruction of the biliary tree were ruled out. Donor age (P = 0.028) and cold ischemic time (CIT) (P = 0.002) were found to be significant risk factors for the development of ITBL.  Organs that were perfused with University of Wisconsin (UW) solution developed ITBL significantly more often than Histidine–Tryptophan–Ketoglutarate (HTK)-perfused organs (P = 0.036). The same applied to organs harvested externally and shipped to our center versus those that were procured locally by our harvest teams (P < 0.001). Pressure perfusion via the hepatic artery significantly reduced the risk of ITBL (P = 0.001). The only recipient factor that showed a significant influence was Child-Pugh score status C (P = 0.021). Immunologic factors had no significant impact on ITBL. The clinical consequences of this study for our institution have been the strict limitation of CIT to <10 h and the exclusive use of HTK solution. We further advocate that all organ procurement teams perform pressure perfusion on harvested organs.

Ancillary